IDseq

IDseq performs hypothesis-free metagenomic pathogen detection and monitoring from next-generation sequencing (mNGS) data.

Key Features:

• Hypothesis-Free Analysis: Operates without prior knowledge of microbial composition or pathogen-specific reagents, enabling unbiased detection across diverse samples.
• Cloud-Based Infrastructure: Executes analyses using cloud computing resources.
• Comprehensive Data Processing: Accepts raw mNGS data and performs host and quality filtration followed by an assembly-based alignment pipeline that assigns reads and contigs to taxonomic categories.
• Visualization of Taxonomic Relative Abundances: Generates visual summaries of taxonomic relative abundances to aid interpretation.
• Environmental Background Modeling: Supports creation and use of environmental background models to provide contextual interpretation of microbial composition.
• Internal Spike-In Control Recognition: Automatically recognizes internal spike-in controls and reports associated statistics.
• Novel Pathogen Detection and Benchmarking: Detects novel pathogens and has been benchmarked with synthetically evolved viral sequences and real-world samples, including analysis of a SARS-CoV-2–positive nasopharyngeal swab.

Scientific Applications:

• Metagenomic pathogen detection: Identification of known and novel pathogens from mNGS datasets.
• Infectious disease research: Characterization of microbial agents implicated in disease.
• Epidemiology and public health surveillance: Monitoring of pathogen emergence and spread using sequencing data.
• Environmental and clinical sample analysis: Comparative analysis of microbial composition across diverse environmental and clinical samples.

Methodology:

Accepts raw mNGS data; performs host and quality filtration; uses an assembly-based alignment pipeline to assign reads and contigs to taxonomic categories; supports environmental background modeling and internal spike-in control recognition; benchmarking performed with synthetically evolved viral sequences and real-world samples including a SARS-CoV-2 nasopharyngeal swab.